Estimating the Size and Scope of the Urologic Oncology Clinical Trials Enterprise
Urol Pract
.
2024 Jul;11(4):627-629.
doi: 10.1097/UPJ.0000000000000598.
Epub 2024 May 8.
Authors
Kristian D Stensland
1
2
3
,
Madison K Krischak
1
,
Merrick Bank
1
4
,
Rishi R Sekar
1
,
Patrick Lewicki
1
2
,
Gretchen A Piatt
2
,
Khurshid Ghani
1
,
Lindsey A Herrel
1
,
Geoffrey D Barnes
5
,
David D Odell
6
,
Ted A Skolarus
7
Affiliations
1
Department of Urology, University of Michigan, Ann Arbor, Michigan.
2
Department of Learning Health Sciences, University of Michigan, Ann Arbor, Michigan.
3
VA Ann Arbor, Ann Arbor, Michigan.
4
Michigan State University College of Human Medicine, East Lansing, Michigan.
5
Department of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan.
6
Department of Thoracic Surgery, University of Michigan, Ann Arbor, Michigan.
7
Department of Surgery, University of Chicago, Chicago, Illinois.
PMID:
38899679
PMCID:
PMC11268800
(available on
2025-07-01
)
DOI:
10.1097/UPJ.0000000000000598
No abstract available
Keywords:
cancer; clinical trials; enrollment.
Publication types
Editorial
MeSH terms
Clinical Trials as Topic*
Humans
Medical Oncology*
Urologic Neoplasms / therapy
Urology
Grants and funding
F32 CA264874/CA/NCI NIH HHS/United States
K12 DK111011/DK/NIDDK NIH HHS/United States
P30 CA046592/CA/NCI NIH HHS/United States